Clinical trials in Cracow – page 3

In Kraków, clinical trials in type 2 diabetes, chronic kidney disease, hyperlipidemia, and hypoparathyroidism are exploring new ways to improve long-term disease control and protect organ function.

• Testing treatments for better blood sugar control
• Evaluating options to slow kidney decline
• Studying hormonal disorders and calcium balance
• Assessing therapies for metabolic complications

These studies aim to refine treatment effectiveness and support patients living with chronic metabolic conditions.

A strong group of studies focuses on cardiovascular disease, heart failure, hypertension, atrial fibrillation, and acute myocardial infarction, with the goal of improving prevention and treatment outcomes.

• Reducing the risk of major heart events
• Improving care for chronic and worsening heart failure
• Studying blood pressure control in difficult-to-treat patients
• Evaluating strategies for stroke and infarction prevention

Several trials in the city are also looking at ways to improve recovery after cardiac procedures and lower future cardiovascular risk.

Many trials in Kraków address immune-mediated diseases such as systemic lupus erythematosus, Sjögren’s syndrome, and psoriatic arthritis, with an emphasis on better symptom control and disease suppression.

• Studying therapies for autoimmune inflammation
• Evaluating treatment effectiveness in lupus and related disorders
• Assessing new approaches for arthritis linked to immune disease
• Exploring long-term safety and tolerability

Research in this area also includes conditions where immune dysfunction affects multiple organs and daily quality of life.

Skin-focused trials cover atopic dermatitis, plaque psoriasis, vitiligo, alopecia areata, and hidradenitis suppurativa, reflecting a broad effort to improve visible and often persistent inflammatory conditions.

• Testing new therapies for chronic skin inflammation
• Evaluating hair regrowth and skin repigmentation
• Studying symptom relief in psoriasis and eczema
• Assessing patient comfort and treatment durability

These studies aim to offer more effective options for people living with conditions that can strongly affect daily well-being.

Trials in asthma, COPD, chronic rhinosinusitis with nasal polyps, and allergic rhinitis are examining ways to improve breathing, reduce flare-ups, and ease chronic airway inflammation.

• Evaluating treatments for severe and difficult-to-control asthma
• Studying new options for chronic obstructive lung disease
• Improving symptom relief in nasal and sinus inflammation
• Looking at long-term control of allergic airway disease

Researchers are especially interested in therapies that may lower exacerbation rates and improve everyday respiratory function.

Clinical research in ulcerative colitis, Crohn’s disease, non-alcoholic steatohepatitis, and alcohol-related liver disease is aiming to improve inflammation control and reduce long-term complications.

• Testing treatments for inflammatory bowel disease
• Evaluating approaches to maintain remission
• Exploring therapies for liver inflammation and damage
• Studying digestive symptoms and quality of life

Some studies also address patients with more complex digestive conditions that need long-term management.

Neurological studies include multiple sclerosis, Alzheimer’s disease, migraine, epilepsy, and narcolepsy, reflecting broad interest in both chronic and progressive brain disorders.

• Assessing treatments for relapsing and progressive nerve disease
• Studying memory and cognitive decline
• Testing therapies for seizure control
• Exploring options for sleepiness and migraine burden

These trials focus on symptom reduction, disease slowing, and better day-to-day functioning for patients with neurological conditions.

Research on breast cancer, non-small cell lung cancer, lymphoma, multiple myeloma, and leukemia is an important part of the trial landscape in Kraków.

• Testing new cancer treatment combinations
• Evaluating strategies for relapsed or hard-to-treat disease
• Studying immune and targeted therapies
• Assessing response and disease control in blood cancers

These studies seek to improve survival, response rates, and treatment options for both solid tumors and blood-related cancers.

Several trials address genetic and rare diseases such as Marfan syndrome, congenital adrenal hyperplasia, nephrotic syndrome, and other inherited conditions.

• Exploring therapies for rare genetic disorders
• Studying hormone and growth-related abnormalities
• Evaluating treatment options for childhood-onset disease
• Improving disease monitoring and symptom management

These studies are especially valuable for patients with uncommon conditions where treatment choices are limited.

Trials in COVID-19, HIV-1 infection, meningococcal infection, and fungal infections are focused on prevention, treatment, and better disease control.

• Testing approaches for viral and bacterial infection management
• Evaluating prevention strategies in high-risk groups
• Studying treatment for acute fungal disease
• Looking at immune protection and infection reduction

This area includes both active treatment studies and work aimed at lowering future infection risk.

Studies in juvenile idiopathic arthritis, axial spondyloarthritis, systemic sclerosis, and chronic pain-related disorders are examining ways to reduce inflammation and improve mobility.

• Evaluating treatments for inflammatory joint disease
• Studying pain relief and functional improvement
• Exploring disease control in connective tissue disorders
• Assessing longer-term symptom management

Researchers are looking for therapies that can ease stiffness, pain, and movement limitations over time.

Trials involving endometriosis, pregnancy-related conditions, contraception, and menopausal symptoms reflect a broad commitment to women’s health research.

• Testing therapies for endometriosis-related pain
• Studying options in reproductive and hormonal health
• Evaluating prevention of pregnancy
• Exploring symptom relief for vasomotor complaints

These studies are designed to improve comfort, planning options, and quality of life across different stages of life.

Some trials focus on behavior change, smoking and vaping cessation, and sleep-related problems such as narcolepsy and excessive daytime sleepiness.

• Supporting quitting nicotine use and vaping
• Studying treatments for sleep-wake disorders
• Assessing changes in alertness and daily functioning
• Exploring behavioral support alongside medical treatment

These studies combine medical and behavioral approaches to help people improve daily habits and alertness.